PHIL

PHIL: Direct-to-Patient Digital Medication Access Platform

PHIL is a company that operates a digital hub and a direct-to-patient platform aimed at pharmaceutical brands. Its proposition focuses on improving treatment starts, coverage, adherence, and commercial performance for retail and specialty-lite medications. The company presents itself as a partner to laboratories, patients, and healthcare professionals.

Services for Pharmaceutical Laboratories

For manufacturers, PHIL offers a comprehensive platform designed to streamline the prescription access experience. The company states that its platform increases access, affordability, and adherence at scale. Its capabilities include:

• Digital hub with end-to-end brand experience, from intake to routing and dispensing.
• Prior Authorization Portal (PA Portal) with one-click PA submissions, script quality checks, and proactive updates.
• Integrated coverage workflows, copay support, financial assistance, and flexible access pathways to reduce out-of-pocket costs.
• Nationwide integrated dispense network with commercial and cash dispense capabilities, free shipping, refill reminders, and delivery.
• Data and insights with program dashboards, AI-assisted workflows, and a dedicated Client Insights team.

The company reports results measured against traditional channels: more than 2x in patient starts, more than 2x in covered dispenses, more than 3x in refill adherence, a PA submission rate above 90%, more than 2x in covered dispenses, a 50-state dispense network, more than 99% plan coverage, more than 3x improvement in GTN, and a patient satisfaction score of 4.9/5.0 on Trustpilot.

Solutions for Patients and Healthcare Professionals

For patients, PHIL offers PHILRx, a service that allows receiving affordable medications directly at home. The platform includes enrollment in minutes, free shipping, easy refills, and order tracking. For healthcare professionals, PHILRx provides in-workflow prescribing tools and prior authorization (PA) tools to improve patient care.

Technology and Data Approach

PHIL describes its approach as human-first, with innovative technology and AI-supported outcomes. Its unified access platform combines advanced data capabilities, AI-powered workflows, and a dedicated Client Insights team to surface opportunities that improve patient outcomes and brand performance. The company also offers a GTN calculator to model a brand's commercial potential and gross-to-net margin impact.

Partnerships and Recent Announcements

Among notable collaborations, PHIL and Sprout Pharmaceuticals expanded a direct-to-patient access program for an innovative women's health brand. Additionally, PHIL and Tenpoint Therapeutics partnered to launch a direct-to-patient cash program for a new ophthalmologic brand.

Resources and Publications

The company publishes reports and resources, such as the report on patient perspectives on the direct-to-patient model, the report on healthcare professional (HCP) perspectives on provider engagement in the digital era, and a document on five key factors to drive brand excellence. It also maintains a resource hub, a press library, and a help center for patients with PHILRx prescriptions.

Corporate Headquarters

PHIL has its corporate headquarters in Scottsdale, Arizona. The company identifies as PHIL Inc. and offers its platform through the domain phil.us.

Location and Contact

14500 N Northsight Blvd, Suite 307, Scottsdale, AZ 85260